Financial - Capital Markets
Compare Stocks
2 / 10Stock Comparison
GEMI vs RKLB
Revenue, margins, valuation, and 5-year total return — side by side.
Aerospace & Defense
GEMI vs RKLB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Financial - Capital Markets | Aerospace & Defense |
| Market Cap | $764M | $45.24B |
| Revenue (TTM) | $142M | $680M |
| Net Income (TTM) | $-501M | $-183M |
| Gross Margin | 8.2% | 36.6% |
| Operating Margin | -116.6% | -33.2% |
| Total Debt | $1.19B | $254M |
| Cash & Equiv. | $43M | $829M |
Quick Verdict: GEMI vs RKLB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GEMI is the clearest fit if your priority is growth exposure.
- Rev growth 44.9%, EPS growth 51.3%
- 44.9% NII/revenue growth vs RKLB's 38.0%
RKLB carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- beta 2.91
- 7.1% 10Y total return vs GEMI's -85.2%
- Lower volatility, beta 2.91, Low D/E 14.7%, current ratio 4.08x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 44.9% NII/revenue growth vs RKLB's 38.0% | |
| Quality / Margins | -26.9% margin vs GEMI's -111.5% | |
| Stability / Safety | Beta 2.91 vs GEMI's 3.31 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +252.5% vs GEMI's -85.2% | |
| Efficiency (ROA) | -8.2% ROA vs GEMI's -28.3%, ROIC -19.9% vs -16.0% |
GEMI vs RKLB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
GEMI vs RKLB — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
RKLB leads this category, winning 5 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
RKLB is the larger business by revenue, generating $680M annually — 4.8x GEMI's $142M. RKLB is the more profitable business, keeping -26.9% of every revenue dollar as net income compared to GEMI's -111.5%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $142M | $680M |
| EBITDAEarnings before interest/tax | -$243M | -$191M |
| Net IncomeAfter-tax profit | -$501M | -$183M |
| Free Cash FlowCash after capex | -$81M | -$316M |
| Gross MarginGross profit ÷ Revenue | +8.2% | +36.6% |
| Operating MarginEBIT ÷ Revenue | -116.6% | -33.2% |
| Net MarginNet income ÷ Revenue | -111.5% | -26.9% |
| FCF MarginFCF ÷ Revenue | -80.8% | -46.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +63.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -17.3% | +41.7% |
Valuation Metrics
Evenly matched — GEMI and RKLB each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $764M | $45.2B |
| Enterprise ValueMkt cap + debt − cash | $1.9B | $44.7B |
| Trailing P/EPrice ÷ TTM EPS | -4.82x | -212.38x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 5.37x | 75.18x |
| Price / BookPrice ÷ Book value/share | — | 24.22x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
RKLB leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | -12.3% |
| ROA (TTM)Return on assets | -28.3% | -8.2% |
| ROICReturn on invested capital | -16.0% | -19.9% |
| ROCEReturn on capital employed | -113.1% | -16.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 |
| Debt / EquityFinancial leverage | — | 0.15x |
| Net DebtTotal debt minus cash | $1.1B | -$575M |
| Cash & Equiv.Liquid assets | $43M | $829M |
| Total DebtShort + long-term debt | $1.2B | $254M |
| Interest CoverageEBIT ÷ Interest expense | -12.78x | -23.34x |
Total Returns (Dividends Reinvested)
RKLB leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RKLB five years ago would be worth $78,659 today (with dividends reinvested), compared to $1,484 for GEMI. Over the past 12 months, RKLB leads with a +252.5% total return vs GEMI's -85.2%. The 3-year compound annual growth rate (CAGR) favors RKLB at 173.3% vs GEMI's -47.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -54.2% | +3.4% |
| 1-Year ReturnPast 12 months | -85.2% | +252.5% |
| 3-Year ReturnCumulative with dividends | -85.2% | +1941.0% |
| 5-Year ReturnCumulative with dividends | -85.2% | +686.6% |
| 10-Year ReturnCumulative with dividends | -85.2% | +706.4% |
| CAGR (3Y)Annualised 3-year return | -47.1% | +173.3% |
Risk & Volatility
RKLB leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
RKLB is the less volatile stock with a 2.91 beta — it tends to amplify market swings less than GEMI's 3.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RKLB currently trades 78.9% from its 52-week high vs GEMI's 10.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.31x | 2.91x |
| 52-Week HighHighest price in past year | $45.89 | $99.58 |
| 52-Week LowLowest price in past year | $3.91 | $20.23 |
| % of 52W HighCurrent price vs 52-week peak | +10.4% | +78.9% |
| RSI (14)Momentum oscillator 0–100 | 52.5 | 57.7 |
| Avg Volume (50D)Average daily shares traded | 1.8M | 21.9M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates GEMI as "Buy" and RKLB as "Buy". Consensus price targets imply 102.9% upside for GEMI (target: $10) vs 17.5% for RKLB (target: $92).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $9.64 | $92.33 |
| # AnalystsCovering analysts | 9 | 18 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
RKLB leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 1 category is tied.
GEMI vs RKLB: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is GEMI or RKLB a better buy right now?
For growth investors, Gemini Space Station, Inc.
Class A Common Stock (GEMI) is the stronger pick with 44. 9% revenue growth year-over-year, versus 38. 0% for Rocket Lab USA, Inc. (RKLB). Analysts rate Gemini Space Station, Inc. Class A Common Stock (GEMI) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — GEMI or RKLB?
Over the past 5 years, Rocket Lab USA, Inc.
(RKLB) delivered a total return of +686. 6%, compared to -85. 2% for Gemini Space Station, Inc. Class A Common Stock (GEMI). Over 10 years, the gap is even starker: RKLB returned +706. 4% versus GEMI's -85. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — GEMI or RKLB?
By beta (market sensitivity over 5 years), Rocket Lab USA, Inc.
(RKLB) is the lower-risk stock at 2. 91β versus Gemini Space Station, Inc. Class A Common Stock's 3. 31β — meaning GEMI is approximately 14% more volatile than RKLB relative to the S&P 500.
04Which is growing faster — GEMI or RKLB?
By revenue growth (latest reported year), Gemini Space Station, Inc.
Class A Common Stock (GEMI) is pulling ahead at 44. 9% versus 38. 0% for Rocket Lab USA, Inc. (RKLB). On earnings-per-share growth, the picture is similar: Gemini Space Station, Inc. Class A Common Stock grew EPS 51. 3% year-over-year, compared to 2. 6% for Rocket Lab USA, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — GEMI or RKLB?
Rocket Lab USA, Inc.
(RKLB) is the more profitable company, earning -32. 9% net margin versus -111. 5% for Gemini Space Station, Inc. Class A Common Stock — meaning it keeps -32. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RKLB leads at -38. 0% versus -116. 6% for GEMI. At the gross margin level — before operating expenses — RKLB leads at 34. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — GEMI or RKLB?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is GEMI or RKLB better for a retirement portfolio?
For long-horizon retirement investors, Rocket Lab USA, Inc.
(RKLB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+706. 4% 10Y return). Gemini Space Station, Inc. Class A Common Stock (GEMI) carries a higher beta of 3. 31 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (RKLB: +706. 4%, GEMI: -85. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between GEMI and RKLB?
These companies operate in different sectors (GEMI (Financial Services) and RKLB (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.